GlassScriptPhysician profile
Morgan Parker
NPI 1871173302
$1,151.60
in general payments reported to CMS, 2019-2025
20 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $386 · 2023: $194 · 2024: $141 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $174.20 | 2021-2025 | Proclaim, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $163.53 | 2021-2025 | Lokelma, Farxiga, Airsupra |
| Novo Nordisk INC | $160.82 | 2021-2025 | Wegovy |
| Pfizer INC. | $122.94 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.30 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.08 | 2022-2023 | Jardiance |
| Amgen INC. | $57.04 | 2021-2022 | |
| Daiichi Sankyo INC. | $52.65 | 2022-2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $34.97 | 2023-2024 | |
| Abbvie INC. | $32.65 | 2025 | |
| Dexcom, INC. | $32.50 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $30.03 | 2022 | |
| Phadia US INC. | $24.25 | 2022 | |
| Eisai INC. | $23.65 | 2025 | |
| Astellas Pharma US INC | $22.84 | 2025 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.00 | 2021 | |
| Innocoll Pharmaceuticals Limited | $17.85 | 2021 | |
| Lilly USA, LLC | $16.72 | 2022 | |
| Merck Sharp & Dohme LLC | $16.61 | 2022 | |
| Gilead Sciences, INC. | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.